VOR
Vor Biopharma Inc
NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY
$14.33
+2.14% today
Updated 2026-04-30
Market cap
$702.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-70.50
Dividend yield
—
52W range
$3 – $66
Volume
1.1M
Vor Biopharma Inc (VOR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — |
| Cost of revenue | $20000.00 | $91000.00 | $1.39M | $4.45M | $8.96M | $3.49M | $3.53M | — |
| Gross profit | $-20000.00 | $-91000.00 | $-1.39M | $-4.45M | $-8.96M | $-3.49M | $-3.53M | — |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $2.43M | $6.20M | $31.62M | $47.53M | $64.55M | $94.31M | $93.31M | $321.53M |
| SG&A | $427000.00 | $4.22M | $11.75M | $21.49M | $28.87M | $31.72M | $27.88M | $50.11M |
| Operating income | $-2.86M | $-10.42M | $-43.37M | $-69.02M | $-93.42M | $-126.04M | $-121.19M | $-371.64M |
| Operating margin | — | — | — | — | — | — | — | — |
| EBITDA | $-2.84M | $-10.14M | $-42.76M | $-67.58M | $-83.13M | $-114.37M | $-117.66M | $-368.75M |
| EBITDA margin | — | — | — | — | — | — | — | — |
| EBIT | $-2.86M | $-10.23M | $-43.37M | $-69.02M | $-92.09M | $-117.86M | $-121.19M | $-371.64M |
| Interest expense | $1.00M | $608000.00 | $0.00 | $1.55M | $1.32M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.15M | $-10.84M | $-43.34M | $-68.90M | $-92.09M | $-117.86M | $-116.91M | $-695.98M |
| Net income growth (YoY) | — | -161.1% | -299.8% | -59.0% | -33.7% | -28.0% | +0.8% | -495.3% |
| Profit margin | — | — | — | — | — | — | — | — |